Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 15/20 | 0.63 |
| ▸ | CA2 | P00918 | 15/20 | 0.63 |
| ▸ | CA6 | P23280 | 14/20 | 0.63 |
| ▸ | CA7 | P43166 | 14/20 | 0.63 |
| ▸ | CA5B | Q9Y2D0 | 13/20 | 0.63 |
| ▸ | CA12 | O43570 | 13/20 | 0.63 |
| ▸ | CA9 | Q16790 | 12/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 12/20 | 0.63 |
| ▸ | CA13 | Q8N1Q1 | 11/20 | 0.63 |
| ▸ | CA3 | P07451 | 9/20 | 0.63 |
| ▸ | CA4 | P22748 | 8/20 | 0.63 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.63 |
| ▸ | CA5A | P35218 | 12/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | KMT5B | Q4FZB7 | 1/20 | 0.42 |
| ▸ | KMT5C | Q86Y97 | 1/20 | 0.42 |
| ▸ | YAP1 | P46937 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2776111 | 0.98 | CA1 (0.65) | CA1CA2CA6CA7CA5B | |
| SCHEMBL2773999 | 0.98 | CA1 (0.65) | CA1CA2CA6CA7CA5B | |
| SCHEMBL2776863 | 0.98 | CA1 (0.65) | CA1CA2CA6CA7CA5B | |
| SCHEMBL2774475 | 0.97 | CA1 (0.59) | CA1CA2CA6CA7CA5B | |
| SCHEMBL2775613 | 0.93 | CA1 (0.55) | CA1CA2CA6CA7CA5B | |
| SCHEMBL2776617 | 0.81 | CA1 (0.53) | CA1CA2CA6CA7CA5B | |
| SCHEMBL2774627 | 0.81 | CA1 (0.53) | CA1CA2CA6CA7CA5B | |
| SCHEMBL2777101 | 0.81 | PTGES2 (0.48) | CA1CA2CA6CA7CA5B | |
| SCHEMBL2775765 | 0.81 | CA1 (0.50) | CA1CA2CA6CA7CA5B | |
| SCHEMBL2777720 | 0.80 | CA1 (0.55) | CA1CA2CA6CA7CA5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2147915-B1 | New cycloalkylated benzothiadiazine derivatives, method of preparing same and pharmaceutical compositions containing them | SERVIER LAB (FR) | 2010-09-15 | — | — | EP | disclosed |
| US-7741320-B2 | Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2010-06-22 | — | — | US | disclosed |
| EP-2147915-A1 | New cycloalkylated benzothiadiazine derivatives, method of preparing same and pharmaceutical compositions containing them | Les Laboratoires Servier (FR) | 2010-01-27 | — | — | EP | disclosed |
| WO-2010004139-A1 | NEW CYCLOALKYLATED BENZOTHIADIAZINE DERIVATIVES, METHOD FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LES LABORATOIRES SERVIER (FR) | 2010-01-14 | — | — | WO | disclosed |
| US-20100009974-A1 | Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compostions containing them | LES LABORATOIRES SERVIER (FR) | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009974-A1 | Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compostions containing them | ACLY, HCAR1, GABRG1 | CA1 3557/4885CA2 1509/4885CA6 3942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.